Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

TVF Communications

- PMLiVE

From molecule to market and beyond: Uniphar announces extended global commercialization platform

Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 57 years in the industry delivering specialist services to more than 200 international clients across 180 countries.

Uniphar

- PMLiVE

Roche’s Alecensa receives NICE recommendation to treat ALK-positive lung cancer

Just under 100 non-small cell lung cancer patients in England will be eligible for the drug

- PMLiVE

British Medical Association GP committee votes to phase out physician associates

The majority of members voted that the role is “fundamentally unsafe” in general practice

- PMLiVE

Influencing the future of healthcare communications

By Claire Knapp and Tapas Mukherjee

- PMLiVE

Innovative Trials named a finalist at the PME Award

Patient recruitment and retention company, Innovative Trials, was shortlisted as a finalist in the PME Award for its collaboration with US non-profit Oliver Patch Project to improve patient outcomes.

Innovative Trials

- PMLiVE

AbbVie’s continuous Parkinson’s disease therapy Vyalev approved by FDA

More than ten million people worldwide are living with the neurological disorder

- PMLiVE

GSK’s investigational antibiotic granted FDA priority review for urinary tract infections

Gepotidacin could be the first in a new class of oral antibiotics for uncomplicated UTIs in over 20 years

- PMLiVE

Stirred becomes first UK health comms agency to achieve EcoVadis Platinum Medal

The rating places Stirred in the top 1% of companies globally in business sustainability assessments

- PMLiVE

Precision, planning and creativity for launch excellence in a volatile sector

The dynamic launch excellence environment has many challenges but is full of opportunity

- PMLiVE

Sex, Gender, and the Brain: The Women’s Brain Foundation and Medscape Education Announce Groundbreaking Learning Centre

LONDON--(BUSINESS WIRE)--The Women’s Brain Foundation (WBF), the global pioneer that has advanced the inclusion of sex- and gender-based evidence-generation in all research, drug development, and healthcare since 2017; and Medscape...

Medscape Education

- PMLiVE

AstraZeneca receives MHRA approval for Wainzua in rare nerve disease ATTRv-PN

The therapy is designed to reduce the effects of the disease by lowering the production of TTR protein

- PMLiVE

Sanofi and Orano Med partner to advance radioligand therapies for rare cancers

The companies will invest in a new entity that will operate under the Orano Med brand

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links